SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-040767
Filing Date
2015-05-08
Accepted
2015-05-08 18:50:05
Documents
2
Period of Report
2015-05-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3812
2 EX-24 DOCUMENT attachment1.htm EX-24 4005
  Complete submission text file 0001209191-15-040767.txt   9539
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address THURGAUERSTRASSE 130 GLATTPARK (OPFIKON) V8 8152
Business Address THURGAUERSTRASSE 130 GLATTPARK (OPFIKON) V8 8152 41 44 878 6000
Baxter Healthcare SA (Reporting) CIK: 0001582211 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36020 | Film No.: 15848285